Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1996-07-12
1998-09-01
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514 80, 514118, 548414, 558171, C07F 922, A61K 3342
Patent
active
RE0358860
ABSTRACT:
pharmaceutically acceptable salt thereof: ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 each represent hydrocarbon groups which may be substituted, except cases in which (1) R.sub.2 is unsubstituted methyl, ( 2 ) R.sub.3 is an unsubstituted hydrocarbon group having 1 to 3 carbon atoms, and (3) R.sub.1 is benzyloxycarbonylaminomethyl, R.sub.2 is isobutyl and R.sub.3 is isobutyl or phenylmethyl, which has endothelin-converting enzyme inhibiting activity and is useful as pharmaceutical drugs such as therapeutic agents for hypertension, cardiac or cerebral circulatory diseases and renal diseases.
REFERENCES:
patent: 4379146 (1983-04-01), Greenlee et al.
patent: 4432972 (1984-02-01), Karanewsky et al.
Proc. Natl. Acad. Sci. USA-"Phosphorus-containing Inhibitors of Antiotensin-converting Enzyme", vol. 79, pp. 2176-2180, Apr. 1982.
Biochemistry, "Phosphonamidates as Transition-State analogue Inhibitors of Thermolysin", 22, 4618-4624, 1982.
Biochemical and Biophysical Res. Comm., "Inhbitions of Biological Actions of Big Endothelin-1 by Phosphoramidon" vol. 172, No. 2, pp. 390-395, 1990.
Grobelny et al, "Binding Enregetics of Phosphorus-containingInhibitors of Thermolysin", Biochemistry, vol. 28, No. 12 pp. 4948-4951, 1989.
Wakimasu, Rule 132 Declaration, Paper #10, File Wrapper of U.S. Patent No. 5,330,978 (admissions).
Morgan et al, "Differential Binding Energy: A Detailed Evaluation of the Influence of Hydrogen-Bonding and Hydrophobic Groups on the Inhibition of Thermolysin by Phosphorus containing Inhibitors", Journal of the American Chemical Society, vol. 113, No. 1, 1991.
Kam et al, "Inhibition of Thermolysin and Carboxypeptidase A by Phosphamidates", Biochemistry, vol. 18, No. 14, pp. 3032-3038, 1979.
Mookhtiar, K.A., et al. "Phosphonamidate Inhibitors of Human Neutrophil Collagenase", Biochemistry, vol. 26, No. 7 (1987) (pp. 1962-1965).
McMahon et al., "Phosphoramidon Blocks The Pressor Activity of Porcine Big Endothelin-1-(1-39) In Vivo and Conversion of Big Endothelin-1-(1-39), 2 Endothelin-1-(1-21) In Vitro", Proceedings National Academy of Science, vol. 88 (Feb. 1991), pp. 703-777.
Rich, H. David, "Peptidase Inhibitors" in Comprehensive Medicinal Chemistry The Rational Design, Mechanistic Study & Therapeutic Application of Chemical Compounds, vol. 2 (Pergamon Press PLC), pp. 391-496 (not continuous), 1990.
Carey, et al., "Reaction and Synthesis": Chapter 11 entitled Multistep Synthesis at pp. 539-553, Advanced Organic Chemicstry, Second Ed. Part B (New York Plenum Press, 1983).
Merz, et al., "Free Perturbation Simulations of the Inhibition of Thermolysin: Prediction of the Free Energy of Binding of a New Inhibitor", J. Am. Chem. Soc., vol. 111, No. 15 (1989), pp. 5649-5658.
Kawada Akira
Mori Masaaki
Wakimasu Mitsuhiro
Conlin David G.
Murray Joseph
Neuner George W.
Richter Johann
Takeda Chemical Industries Ltd.
LandOfFree
Phosphonic acid derivatives and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphonic acid derivatives and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphonic acid derivatives and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-258503